Published • loading... • Updated
After Be Bio shutdown, its CEO heads to Orbis; Enanta's longtime chief Jay Luly to retire
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
After Be Bio shutdown, its CEO heads to Orbis; Enanta's longtime chief Jay Luly to retire
→ Former Be Biopharma chief Joanne Smith-Farrell has landed at Orbis Medicines, an Eli Lilly- and Novo-backed startup that's developing oral macrocycles. Smith-Farrell replaces co-founder Morten Graugaard as CEO of Orbis ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
